Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.


International Journal of Thoracic Medicine

Guidelines for Authors

Patient Consent
Plagiarism Policy
Color Illustrations
SI Units
Digital Object Identifier (DOI)
Supplementary Material
Page Charges
Self-Archiving/Green Open Access, Author's ChoiceTM,
   Funding Organizations (NIH etc.)

E-pub First
Financial Disclosure and Conflicts of Interest
Further Information


Manuscripts written in English should be submitted online:

Online Manuscript Submission

Should you experience any problems with your submission, please contact res@karger.com

Editorial Office 'Respiration'
P.O. Box
CH–4009 Basel (Switzerland)
Tel. +27 79 341 4419
Fax +41 61 306 1434

All manuscripts must be accompanied by a covering letter signed by all authors. Assurance should be given that the manuscript is not under simultaneous consideration by any other publication. The preferred word processing package is Word for Windows®. Presentation of manuscripts should conform with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (see N Engl J Med 1997;336:309–315).


All manuscripts are subject to an editorial process involving the Editor-in-Chief, an Associate Editor and reviewers. Notification can be expected within two months from the date of receipt. Submission of an article for publication implies the transfer of the copyright from the author to the publisher upon acceptance. Accepted papers become the permanent property of 'Respiration' and may not be reproduced by any means, in whole or in part, without the written consent of the publisher. It is the author's responsibility to obtain permission to reproduce illustrations, tables, etc. from other publications.
For legal reasons, we must receive your 'Submission Statement' with your original (hand-written) signature. Please download, print, sign and either fax or scan it to make it legally binding.

Clinical Trials: In accordance with the recommendations of the International Committee of Medical Journal Editors, the journal requires that all clinical trials having commenced on or after 1 July 2005 be registered in a public trial registry accessible free of charge. Please consult http://www.icmje.org/index.html#clin_trials for further details. 'Respiration' has implemented the expanded definition stating that 'any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes'. Health-related interventions include any intervention used to modify a biomedical or health-related outcome (for example, drugs, surgical procedures, devices, behavioral treatments, dietary interventions, and process-of-care changes). Health outcomes include any biomedical or health-related measures obtained in patients or participants, including pharmacokinetic measures and adverse events. Purely observational studies (those in which the assignment of the medical intervention is not at the discretion of the investigator) will not require registration.


The journal consists of the following sections:

  1. Thematic Review Series
  2. Editorial Comments
  3. Clinical Investigations
  4. Interventional Pulmonology
  5. Basic Science Investigations
  6. New Drugs in Respiratory Medicine
  7. Technical Notes
  8. The Eye Catcher
  9. Novel Insights from Clinical Practice
  10. What Is Your Diagnosis?
  11. Reviews
  12. Guidelines
  13. The Opinion Corner
  14. Clinico-Pathological Conferences
  15. Letters to the Editor
  16. Congress Calendar

Reviews: Invited reviews, if accepted, are not subject to page charges. Unsolicited reviews may also be submitted for consideration.

Letters addressed to the Editor are encouraged if they directly concern articles previously published in this journal and clinical subjects related to the matters discussed. The editor reserves the right to submit copies of such letters to the authors of the articles concerned prior to publication in order to permit them to respond in the same issue of the journal. But letters on general scientific or medical subjects in respiratory medicine are also welcome. Letters to the Editor should be no longer than one printed page.

Eye Catchers: Maximum 1 printed page. Text may not exceed 250 words to allow sufficient space for pictorial material, which is the main object of an Eye Catcher. Maximum 2 references and 2–5 keywords.

Novel Insights from Clinical Practice (formerly Case Reports): Maximum 7 authors. The publication space available for case reports is very limited. The journal only considers case reports with significant new insights or with an extremely unusual and memorable course. Highlighted boxes containing one or two bullet points on 'Established facts' (what is already known) and 'Novel insights' (what new information has been gained) are required and should be placed on the first page of the report. These should be selected so as to reinforce the novelty of the clinical observation. The text per box should be limited to 1–2 very short sentences. The manuscript should be presented with an abstract (unstructured, max. 200 words), followed by introduction, case report and discussion. Maximum 3 figures.

What Is Your Diagnosis?: Select catchy title not disclosing the diagnosis. Page 1: Case report and 1–2 illustrations and the question 'What Is Your Diagnosis'. Page 2: The diagnosis followed by a short description of what diagnostic procedures were done to reach the diagnosis and the discussion with references. Maximum 15 references and include 3–5 keywords.

Guidelines: Consensus Guidelines are welcome from working groups to provide guidance in key and emerging areas in all fields of respiratory medicine. Such guidelines are also subject to a reviewing process.

Patient Consent

This is required for ALL articles containing personal information about the patient submitted for publication in the following sections:

  Novel Insights from Clinical Practice
  What Is Your Diagnosis?
  Eye Catcher

Signed patient consent (please use this Patient Consent Form) must be obtained from the patient, guardian or next of kin (or a statement that the patient was not alive at the time of writing) and sub­mitted along with the manuscript.

Plagiarism Policy

Whether intentional or not, plagiarism is a serious violation. We define plagiarism as a case in which a paper reproduces another work with at least 25% similarity and without citation.
If evidence of plagiarism is found before/after acceptance or after publication of the paper, the author will be offered a chance for rebuttal. If the arguments are not found to be satisfactory, the manuscript will be retracted and the author sanctioned from publishing papers for a period to be determined by the responsible Editor(s).


Pages should be numbered throughout the manuscript text.

Title page: The first page of each paper should indicate the title, the authors' names, the institute where the work was conducted, and a short title for use as running head.

Full address: The exact postal address of the corresponding author complete with postal code must be given at the bottom of the title page. Please also supply phone and fax numbers, as well as e-mail address.

Key words: For indexing purposes, a list of 3–7 key words is essential.

Abstract: Each paper needs an abstract of up to 250 words. Abstracts of papers submitted for publication in the sections Clinical Investigations, Basic Science Investigations, Interventional Pulmonology, and Technical Notes should be structured as follows:

    Background: What is the major motive that prompted the study?
    Objectives: What is the purpose of the study?
    Methods: How was the study done?
    Results: Most important findings.
    Conclusions: Most important conclusions.

Introduction: What is the main question? State your considerations leading to the formulation of this question.

Material and Methods: Prior approval of an Institutional Review Board (IRB) is required for all investigations involving human subjects and animals. Animal experimentation must be performed according to the Helsinki Declaration.

Study design: Provide a short survey of the tests or experiments. Include the independent variable(s) manipulated, the dependent variable(s) measured and all controls.

Methods: Describe methods and apparatus in detail. Provide references and brief description of methods already published. Identify drugs and chemicals, including generic name, dosage and administration. Describe the pre-study condition of patients or animals.

Analysis: Define the variables. Use statistical analysis that is appropriate for the study. Describe statistical methods used for each analysis; provide references for tests that are not well known.

Results: A concise report of important results only. Use figures and tables for the presentation of data; summarize the most important observations in the text. Start and end dates of the study must be indicated (from ... to, preferably exact dates, but at least months and year[s]).

Discussion: Summarize main results and make sure you can answer the question asked in the introduction, briefly supporting the answer with the relevant results. Explain and defend the answer, comment on contradictory or unexpected results and discrepancies with previous findings. Elaborate on new and important aspects of the study.

Acknowledgements: Use this section to name persons who have contributed to the article, but whose contributions do not justify authorship.

Footnotes: Avoid footnotes. When essential, they are numbered consecutively and typed at the foot of the appropriate page.

Tables and Illustrations: Tables and illustrations (both numbered in Arabic numerals) should be prepared on separate sheets. Tables require a heading and figures a legend, also prepared on a separate sheet. Due to technical reasons, figures with a screen background should not be submitted. When possible, group several illustrations in one block for reproduction (max. size 180 x 223 mm) or provide crop marks. Each illustration must be labelled with its number and the first author's name. b/w half-tone and color illustrations must have a final resolution of 300 dpi after scaling, line drawings one of 800–1,200 dpi. Figure files must not be embedded in a document file but submitted separately.

Color Illustrations

Online edition: Color illustrations are reproduced free of charge. In the print version, the illustrations are reproduced in black and white. Please avoid referring to the colors in the text and figure legends.

Print edition: Up to 6 color illustrations per page can be integrated within the text at CHF 960.00 per page.


In the text identify references by Arabic numerals [in square brackets]. Material submitted for publication but not yet accepted should be noted as ‘unpublished data’ and not be included in the reference list. The list of references should include only those publications which are cited in the text. Do not alphabetize; number references in the order in which they are first mentioned in the text. The surnames of the authors followed by initials should be given. There should be no punctuation other than a comma to separate the authors. Preferably, please cite all authors. Abbreviate journal names according to the Index Medicus system. Also see International Committee of Medical Journal Editors: Uniform requirements for manuscripts submitted to biomedical journals (www.icmje.org).


(a) Papers published in periodicals:
Sun J, Koto H, Chung KF: Interaction of ozone and allergen challenges on bronchial responsiveness and inflammation in sensitised guinea pigs. Int Arch Allergy Immunol 1997;112:191–195.

(b) Papers published only with DOI numbers:
Theoharides TC, Boucher W, Spear K: Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients. Int Arch Allergy Immunol DOI: 10.1159/000063858.

(c) Monographs:
Matthews DE, Farewell VT: Using and Understanding Medical Statistics,
ed 3, revised. Basel, Karger, 1996.

(d) Edited books:
Parren PWHI, Burton DR: Antibodies against HIV-1 from phage display libraries: Mapping of an immune response and progress towards antiviral immunotherapy; in Capra JD (ed): Antibody Engineering. Chem Immunol. Basel, Karger, 1997, vol 65, pp 18–56.

Reference Management Software: Use of EndNote is recommended for easy management and formatting of citations and reference lists.

SI Units

Since the United States of America and other countries outside Europe where 'Respiration' is read have not accepted the SI System, authors using SI Units should add the conventional units in parentheses, for example: p02 = 10 kPa (75 mm Hg).

Digital Object Identifier (DOI)

S. Karger Publishers supports DOIs as unique identifiers for articles. A DOI number will be printed on the title page of each article. DOIs can be useful in the future for identifying and citing articles published online without volume or issue information. More information can be found at www.doi.org

Supplementary Material

Multimedia files and other supplementary files, directly relevant but not essential to the conclusions of a paper, enhance the online version of a publication and increase its visibility on the web. These files will undergo editorial review. The Editors reserve the right to limit the scope and length of the supplementary material. Multimedia and supplementary material should meet production quality standards for publication without the need for any modification or editing. Files should not exceed 10 MB in size. Figures and tables need to have titles and legends, and all files should be supplied separately and labeled clearly. All supplementary material should be referred to in the main text. A DOI number will be assigned to supplementary material and it will be hosted online at https://karger.figshare.com under a CC BY license. Authors will be charged a processing fee of CHF 250.00 for supplementary material.

Page Charges

There are no page charges for papers of 4 or fewer printed pages (including tables, illustrations and references). Each additional complete or partial page is charged to the author at CHF 325.00. The allotted size of a paper is equal to approx. 12 manuscript pages (including tables, illustrations and references).

Self-Archiving/Green Open Access

Karger permits authors to archive their pre-prints (i.e. pre-peer review) or post-prints (i.e. accepted manuscript after peer review but before production) on their personal or their institution’s internal website. In addition, authors may post their accepted manuscripts in public Open Access repositories and scientific networks (e.g. ResearchGate or Mendeley) no earlier than 12 months following publication of the final version of their article. For all self-archiving, the posted manuscripts must:

  • Be used for noncommercial purposes only
  • Be linked to the final version on www.karger.com
  • Include the following statement:

‘This is the peer-reviewed but unedited manuscript version of the following article: [insert full citation, e.g. Cytogenet Genome Res 2014;142:227–238 (DOI: 10.1159/000361001)]. The final, published version is available at http://www.karger.com/?doi=[insert DOI number].’

It is the author’s responsibility to fulfill these requirements.

For papers published online first with a DOI number only, full citation details must be added as soon as the paper is published in its final version. This is important to ensure that citations can be credited to the article.

Manuscripts to be archived in PubMed Central due to funding requirements will be submitted by Karger on the author’s behalf [see Funding Organizations (NIH etc.)].

For self-archiving Author's ChoiceTM (Gold Open Access) articles, see Author's ChoiceTM.

Author's ChoiceTM

Karger’s Author's ChoiceTM service broadens the reach of your article and gives all users worldwide free and full access for reading, downloading and printing at www.karger.com. The option is available for a one-time fee of CHF 3,000.00, which is a permissible cost in grant allocation. More information can be found at www.karger.com/authors_choice.
The final, published version of the article may be posted at any time and in any repository or on other websites, in accordance with the relevant Creative Commons license. Reposted Open Access articles must:

  • Follow the terms of the relevant Creative Commons license
  • Be linked to the final version on www.karger.com
  • Include the following statement:

‘The final, published version of this article is available at http://www.karger.com/?doi=[insert DOI number].’

It is the author’s responsibility to fulfill these requirements.

For papers published online first with a DOI number only, full citation details must be added as soon as the paper is published in its final version. This is important to ensure that citations can be credited to the article.

Funding Organizations (NIH etc.)

The U.S. National Institutes of Health (NIH) Public Access Policy mandates that accepted, peer-reviewed manuscripts are archived in its digital database, PubMed Central (PMC), within 12 months of the official publication date. As a service to authors, Karger submits NIH-funded articles to PMC on behalf of the authors immediately upon publication. The NIH assigns a PMCID within approximately 1 month and the manuscript will appear in PMC after a 12-month embargo. For authors making their paper Open Access through Author's ChoiceTM, the embargo will be overridden, thereby accelerating the accessibility of the article. Karger also complies with other funders’ requirements (including Wellcome Trust and RCUK) for submission to PMC.
Authors should include information on their grant in the Acknowledgements section of their papers.


Unless indicated otherwise, proofs are sent to the corresponding author and should be returned with the least possible delay. Alterations other than the correction of printer's errors are charged to the author.

E-pub First

All articles are published electronically ahead of print with a DOI number and are supplemented later with the definite reference of the printed version. The articles become available immediately after the authors' approval to publication, with the added advantage of being citable much earlier than in print. Authors can influence the time of appearance by promptly returning the proofs.


Order forms and a price list are sent with the proofs. Orders submitted after the issue is printed are subject to considerably higher prices.

Financial Disclosure and Conflicts of Interest

Authors must disclose any and all financial involvement in any organization with a direct financial interest in the subject discussed in the submitted manuscript.
Any conflict of interest for a given manuscript must be dealt with according to the statement of the International Committee of Medical Journal Editors (the ‘Vancouver Group’) (Lancet 1993;341:742).

Further Information

For any further details please contact Respiration's Editorial Office.